The Effects of Pregabalin and the Glial Attenuator Minocycline on the Response to Intradermal Capsaicin in Patients with Unilateral Sciatica

@article{Sumracki2012TheEO,
  title={The Effects of Pregabalin and the Glial Attenuator Minocycline on the Response to Intradermal Capsaicin in Patients with Unilateral Sciatica},
  author={Nicole M. Sumracki and Mark R. Hutchinson and Melanie Gentgall and Nancy E. Briggs and Desmond B. Williams and Paul Edward Rolan},
  journal={PLoS ONE},
  year={2012},
  volume={7}
}
Background Patients with unilateral sciatica have heightened responses to intradermal capsaicin compared to pain-free volunteers. No studies have investigated whether this pain model can screen for novel anti-neuropathic agents in patients with pre-existing neuropathic pain syndromes. Aim This study compared the effects of pregabalin (300 mg) and the tetracycline antibiotic and glial attenuator minocycline (400 mg) on capsaicin-induced spontaneous pain, flare, allodynia and hyperalgesia in… 

Tables from this paper

Effect of Minocycline on Lumbar Radicular Neuropathic Pain: A Randomized, Placebo-controlled, Double-blind Clinical Trial with Amitriptyline as a Comparator

The effect size of the minocycline and amitriptyline groups in this randomized, double-blind, placebo-controlled clinical trial is not likely to be clinically meaningful.

Pregabalin and gabapentin for the treatment of sciatica

A data science approach to the selection of most informative readouts of the human intradermal capsaicin pain model to assess pregabalin effects

This study aimed at ranking the various readouts of a human capsaicin–based pain model with respect to the most relevant information about the effects of a potential reference analgesic and identified the pain intensities in the area of secondary hyperalgesia and of allodynia as the most suitable parameters to quantify the analgesic effects of pregabalin.

Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations

It is suggested that this paradoxical state of increased nociception results from acute and long-term exposure to opioids, and appears to develop in a substantial subset of patients using opioids, be considered an additional target of clinical treatment for chronic pain.

Central sensitization in humans: assessment and pharmacology.

Linking patients QST profile with drug efficacy profile may provide the fundamentals for developing individualized, targeted pain management programs in the future and provides new valuable information in drug development and for optimizing the management regimes for chronic pain.

References

SHOWING 1-10 OF 45 REFERENCES

Effect of morphine and pregabalin compared with diphenhydramine hydrochloride and placebo on hyperalgesia and allodynia induced by intradermal capsaicin in healthy male subjects.

Intradermal capsaicin as a neuropathic pain model in patients with unilateral sciatica.

The responses to intradermal capsaicin are quantitatively and qualitatively different in unilateral sciatica patients compared with pain-free controls.

Capsaicin-induced flare and vasodilatation in patients with post-herpetic neuralgia

Contralateral hyperalgesia and allodynia following intradermal capsaicin injection in man

This is the first demonstration of a contralateral response following a unilateral stimulus in man, and bilateral neural pathways mediating contralsateral responses may have a role in the pathophysiology of chronically painful or inflammatory diseases and a confounding influence on using the contral lateral limb as a control experimentally.

Capsaicin evoked pain and allodynia in post-herpetic neuralgia